More Education

Blog Pharmacists Poised to Play Larger Role in Uptake of Biosimilars

With the backing of new laws, retail pharmacists have considerable freedom to switch patients to FDA approved interchangeable biosimilars. While most are willing to use that freedom, according to a new report, unanswered questions remain.

Read More

Related Content

Paper Access to Biosimilars: Impact of Insurance Design

Paper Focus on Access: The Value of Treatment

Paper Progress & Potential in the Biosimilar Market

Stay Informed View the latest newsletter

To receive regular newsletters and periodic alerts from the BPC, enter your email address in the form below:

(function($) {window.fnames = new Array(); window.ftypes = new Array();fnames[0]='EMAIL';ftypes[0]='email';fnames[1]='FNAME';ftypes[1]='text';fnames[2]='LNAME';ftypes[2]='text';}(jQuery));var $mcj = jQuery.noConflict(true);